Core Viewpoint - The announcement by Huaren Health highlights the introduction of a "dual directory" mechanism by the National Medical Insurance Administration, which aims to complement the basic medical insurance directory with a commercial health insurance innovative drug directory, creating a new payment channel for the pharmacy industry [1] Group 1: Company Initiatives - The company has established a dedicated commercial insurance business department to facilitate cooperation with insurance companies and third-party firms [1] - Huaren Health is actively engaging with insurance companies on the Huiminbao project and has signed direct payment agreements with multiple insurers to enable direct claims at pharmacy stores for drugs listed in the commercial insurance directory [1] - The company is designing "insurance + drugs + services" packages to provide more comprehensive health protection services for patients [1] Group 2: Industry Trends - The integration of "medical-pharmaceutical-insurance" ecosystems is identified as a future trend, emphasizing the importance of collaboration between these sectors [1] - The company is implementing data sharing with the commercial insurance system to optimize prescription verification, expedite claims processing, and share medication details, thereby enhancing user experience and promoting deeper integration of the "medical-pharmaceutical-insurance" ecosystem [1]

公司上半年整体客流增长较为明显、客单同环比均略有下降。主要有以 下几方面原因： 首先，医保政策改革：个账资金减少、门诊统筹政策导致客流回流至医 院及社区门诊，同时，慢性病长期处方的单次购买量受限，对药店的客单和 销售产生直接影响。其次，购买渠道分流：以O2O平台为代表的新零售渠道凭 借价格补贴优势和"30分钟送达"的便捷服务，进一步分流传统药店的客流。 再次，市场过度竞争：全国药店高峰值突破70万家，导致店均服务人数降至 2000左右，市场竞争加剧，单店运营效率承压。另外，消费行为变化：消费 者趋于理性化，对价格敏感度提升，更加注重高性价比的产品和服务。 证券代码：301408 证券简称：华人健康 安徽华人健康医药股份有限公司 投资者关系活动记录表 编号：2025-003 投资者关系活动类别 特定对象调研 ☐ 分析师会议 ☐ 媒体采访 ☐ 业绩说明会 ☐ 新闻发布会 ☐ 路演活动 ☐ 现场参观 其他（电话会议） 参与单位名称及人 员姓名 东北证券 文将儒 中信证券 魏通 甬兴证券 胡荣杰 嘉实基金 程佳 同泰基金 唐之超 汇丰晋信 刘哲华 君和立成 崔雨菲 南方基金 尹力 新华资产 李浩 上汽颀臻 沈怡雯 W ...